Multiple Sclerosis Clinical Trial
Official title:
Alexithymia Frequency and Interhemispheric Transfer in Patients With a First Demyelinating Event: Initial Phase of Multiple Sclerosis
Prevalence of alexithymia in multiple sclerosis (MS) is closed to 50% but is unknown in
clinically isolated syndrome (CIS).The present study sought to characterize alexithymia in
CIS patients and his link between psycho behavioral and cognitive disturbances.
In this context, the objectives of the present study were to (a ) define the prevalence of
alexithymia in CIS patients, (b ) to study this relation between psycho behavioral and
cognitive disorders frequently encountered in MS.
The aim to recruit 40 CIS patients with at least two subclinical lesions on brain MRI.
Patients are tested only one month at least after steroids intake and after 6 weeks at least
after any relapse. The control group include 40 right -handed participants; each of them are
matched for age, gender, and education level with a CIS patient.
The parameters to be evaluated are:
The prevalence of alexithymia is assessed by The Toronto Alexithymia Scale TAS-20, a
self-reported scale. The TAS-20 total score corresponds to global level of alexithymia, as
the sum of these three subdomains: 1.Difficulties in Identifying Feelings (DIF); 2.
Difficulties in Describing Feelings (DDF); 3. Externally Oriented Thinking (EOT).
Standard neurological examination is performed by a neurologist using the Kurtzke Expanded
Disability Status Scale (EDSS ).
The standardized neuropsychological battery, named BCcogSEP, is administrated. The BCcogSEP
is made of eight tests commonly impaired in MS. Fourteen scores were obtained and a score was
considered impaired when it was inferior to 5th percentile range compared to the normal
range. The number of impaired scores are considered and a cognitive impairment is considered
when 4 scores are superior or equal to percentile 5th.
For psychobehavioral assessments, the investigators estimated (a) depression (according to
the Beck Depression Inventory; BDI (30)) and anxiety (according to the State-Trait Anxiety
Inventory (31)); (b) apathy (according to the Lille Apathy Rating Scale (32)); (c) empathy
(according to Interpersonal Reactivity Index; IRI).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|